Altimmune, Inc. (ALT) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-05 14:15:56 ET
Altimmune, Inc. (ALT) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST
Company Participants
Jerome Durso - Chairman, CEO & President
Christophe Arbet-Engels - Chief Medical Officer
Linda Richardson - Chief Commercial Officer
Gregory Weaver - Chief Financial Officer
M. Roberts - Chief Scientific Officer
...
Read the full article on Seeking Alpha
For further details see:
Altimmune, Inc. (ALT) Q4 2025 Earnings Call Transcript
Altimmune Inc.
NASDAQ: ALT
ALT Trading
4.31% G/L:
$3.99 Last:
1,325,378 Volume:
$3.90 Open:
ALT Latest News
March 05, 2026 07:00:00 am
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
February 26, 2026 05:00:00 pm
Forget Altimmune: This Proven Obesity?Drug Giant Is the Better Weight?Loss Play
ALT Stock Data
$533,138,746
107,868,919
0.53%
58
N/A
Biotechnology & Life Sciences
Healthcare
US
Gaithersburg
